<html>
<head>
    <meta name="GENERATOR" content="Microsoft Visual Studio 6.0">
    <title>Biological Use Authorization</title>
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/ORA1.css"> -->
    <!-- <link rel="stylesheet" type="text/css" href="/appAsp/Include/Ora_BlueTables.css"> -->
    <link rel="stylesheet" type="text/css" href="/OrPortal/Forms/Compliance/IBC/IBC.css">
    <!-- Get Database Subroutines -->
    
    <!-- End Get Database Subroutines -->
    <!-- #XXXinclude virtual = "/appAsp/Include/StringUtilities.asp" -->
    
    <style>
.OriginalValuesBorder {
    border:3px solid orange;margin-top:5px;
}
.OriginalValuesTitle {
    color:orange;
    font-weight:bold;
}
.highlight {
    background-color:lightyellow; 
    border:1px solid orange;
    padding:2px;
}
.SemiHighlight {
    color:orange;
}
.warning {
    background-color:#FFE4C4; 
    border:1px solid orange;
    padding:2px;
}

th, .thBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-weight:bold;
	font-family:verdana;
}
td, .tdBlue	{
	text-align:left;
	vertical-align:top;
	font-size:8pt;
	font-family:verdana;
}

.THLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
	font-weight:bold;
}
.TDLine1 {
	color:navy;
	background:#F5F5F5;
	font-size:8pt;
}

.THLine2 {
	color:navy;
	background:white;
	font-size:8pt;
	font-weight:bold;
}
.TDLine2 {
	color:navy;
	background:white
	font-size:8pt;
}


.GlobalTd {
	background:white;
	color:navy;
	font-size:9pt;
}
.hdg1 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}
.xxxhdg2 {
	background:white;
	color:brown;
	font-size:11pt;
	font-weight:bold;
}
.hdg2 {
	background:navy;
	color:white;
	font-size:11pt;
	font-weight:bold;
	margin:1px;
	border-width:1px;
	border-color:white;
	padding:2px;
}
.hdg3 {
	background:white;
	color:navy;
	font-size:12pt;
	font-weight:bold;
}


</style>
    <script>window.status='ORA Production Database';</script>
</head>
<body>
    <form action method="POST" id="form1" name="form1">
        <!-- Outer Table -->
        <table width="650" cellpadding="2" cellspacting="0" border="1">
            <tr>
                <td class="GlobalTd">
                    <script>window.status='ORA Production Database';</script><table width="100%" cellpadding="0" cellspacing="0" border="0px">
<tr>
<td>Protocol#: B-20170017<br><br><div class="hdg1" align="center">University of California, Riverside<br>Institutional Biosafety Committee (IBC)<br>Application for Biological Use Authorization Registration</div>
<br><div class="hdg2">A. INVESTIGATOR DATA</div>
<table border="0" cellpadding="1" cellspacing="1" width="100%">
<tr>   <th class="THBlue">Principal Investigator</th>   <td class="TDBlue">Huinan  Liu</td>
<td rowspan="10">&#160;&#160;&#160;&#160;&#160;</td>   <th class="THBlue">Email</th>   <td class="TDBlue">huinan.liu@ucr.edu</td>
</tr>
<tr>   <th class="THBlue">Department</th>   <td class="TDBlue">Bioengineering</td>   <th class="THBlue">Phone</th>   <td class="TDBlue">(951) 827-2944</td>
</tr>
<tr>   <th class="THBlue">Project Start/End Date</th>   <td class="TDBlue">8/1/2017-7/31/2020</td>   <th class="THBlue">Fax</th>   <td class="TDBlue">(951) 827-6416</td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Project Title:</th>
</tr>
<tr>   <td class="TDBlue" colspan="5">Cell Interactions with Biomaterials - Huinan Liu Lab BUA</td>
</tr>
<tr>   <th class="THBlue" colspan="5">
<br>Related Funding Agency(ies) (add as many as apply, even if use of rDNA is identical for each project):</th>
</tr>
<tr>   <td class="TDBlue" colspan="5">Huinan Liu Lab BUA
Biomaterials for tissue repair (NIH, NSF, American Heart Association, N2 Biomedical)
Conductive materials for nerve regeneration (UCR Seed, City of Hope)
Stem cell interactions with biomaterials (California Institute of Regenerative Medicine (CIRM)
Resorbable Metallic Biomaterials for Bone regeneration (NSF, NIH)
Resorbable Materials for Aneurysm Treatment (AHA, NIH)
Biomaterials for Urilogical applications (NIH)
Antimicrobial materials and surfaces (NIH,UCR Senate)</td>
</tr>
<tr><td colspan="5">&#160;</td></tr>
<tr>   <th class="THBlue" colspan="2">Additional Contact person and phone # (if not or in addition to the PI):</th>   <td class="TDBlue" colspan="2">Nhu-Y Nguyen 4083160114</td>
</tr>
</table>
<br><br><div class="hdg2">B. RESEARCH LOCATIONS</div>
<table border="1" width="100%" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue" width="15%">Building &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Room #  &#160;&#160;&#160;</th>   <th class="THBlue" width="55%">List any containment facilities or equipment (biosafety cabinets, etc.) and their last certification dates. &#160;&#160;&#160;</th>   <th class="THBlue" width="15%">Certification<br>Date</th>
</tr>
<tr>   <td class="TDBlue">MSE&#160;&#160;&#160;</td>   <td class="TDBlue">269 and 279&#160;&#160;&#160;</td>   <td class="TDBlue">Biosafety Cabinets in MSE 279&#160;&#160;&#160;</td>   <td class="TDBlue">6/1/2016&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Bourns&#160;&#160;&#160;</td>   <td class="TDBlue"> B 360A &#160;&#160;&#160;</td>   <td class="TDBlue">Biosafety Cabinet &#160;&#160;&#160;</td>   <td class="TDBlue">9/29/2015&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Keen Hall Stem Cell Core&#160;&#160;&#160;</td>   <td class="TDBlue">Rm# A1018 &#160;&#160;&#160;</td>   <td class="TDBlue">Biosafety Cabinet&#160;&#160;&#160;</td>   <td class="TDBlue">7/1/2015&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MSE&#160;&#160;&#160;</td>   <td class="TDBlue">279&#160;&#160;&#160;</td>   <td class="TDBlue">Biosafety Cabinet &#160;&#160;&#160;</td>   <td class="TDBlue">6/5/2017&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Bourns&#160;&#160;&#160;</td>   <td class="TDBlue"> B 360A &#160;&#160;&#160;</td>   <td class="TDBlue">Biosafety Cabinet &#160;&#160;&#160;</td>   <td class="TDBlue">6/5/2017&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Keen Hall Stem Cell Core&#160;&#160;&#160;</td>   <td class="TDBlue">Rm# A1018 &#160;&#160;&#160;</td>   <td class="TDBlue">Biosafety Cabinet &#160;&#160;&#160;</td>   <td class="TDBlue">6/8/2017&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MSE&#160;&#160;&#160;</td>   <td class="TDBlue">269&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
</table>
<br><br><div class="hdg2">C. PRIOR APPROVAL STATUS</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Application Type</th>   <td width="50%" class="TDBlue">Renewal</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, please list the number of the approved protocol</th>   <td class="TDBlue">B-20140020</td>
</tr>
<tr>   <th class="THBlue">Does this project involve human or animal subjects, or a positive disclosure of a conflict of interest (income, loans, or management role in funding source, etc.)?</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has this project been reviewed by any other UCR review boards?  If so, indicate the relevant protocol numbers and approval dates:</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">IRB (human subjects)</th>   <td class="TDBlue">HS-12-098; HS-15-182</td>
</tr>
<tr>   <th class="THBlue">IACUC (animal subjects)</th>   <td class="TDBlue">A-20110047E; A-20140032</td>
</tr>
<tr>   <th class="THBlue">Conflict of interest (provide approval date)</th>   <td class="TDBlue">No</td>
</tr>
<tr>   <th class="THBlue">Does this project involve strains of plant or animal pathogens not originating in California?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, CDFA and APHIS permits may be required.  List the relevant permit numbers and dates covered:</th>
</tr>
<tr>   <th class="THBlue">CDFA</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">APHIS</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Do experiments involve releasing organisms containing rDNA into the environment?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;Yes&#8221;, has an application for this release been filed with a state or federal regulatory agency?	Agency and date filed:</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Will you be using  a "Select Agent" (<a href="http://www.cdc.gov/od/ohs/lrsat.htm">www.cdc.gov/od/ohs/lrsat.htm</a>)</th>   <td class="TDBlue">False</td>
</tr>
</table>
<br><br><div class="hdg2">DESCRIPTION OF PROJECT</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Provide a brief, non-technical description and purpose of the project.</th>
</tr>
<tr>   <td class="TDBlue">The overall goal is to design and fabricate biomaterial scaffolds for bone, cartilage and neural regeneration. Candidate materials include biodegradable metals (e.g. magnesium alloys, iron alloys), graphene, collagen hydrogels and composites. Additional surface coatings can improve cellular adhesion and control biomaterial degradation. Cellular biocompatibility, cytotoxicity, and stem cell differentiation will be determined using both stem cells and differentiated cell types. This research is essential to verify the biocompatibility of a scaffold prior to conducting any in vivo experiments. 
    We will be obtaining fresh human blood to test the hemocytocompatability of new materials.  A circulation flow device will be developed for this test.
     We will be testing E. coli (ATTC 25922) and other non pathogenic bacteria (Enterobacter aerogenes ATCC 35028,Bacillus subtilis ATCC 7060,
Serratia marcescens ATCC 8195, S. Epidermidis), Pseduomonas aeruginosa (ATCC 29260), Staphylococcus aureus(ATCC 25923), Methicillin Resistant Staphylococcus aureus (MRSA, ATCC 33591)
with biomaterials as part of a study on resorbable implant materials for urilogical applications. We will be testing microorganisms, such as Candida albican, Candida glabrata, and their drug-resistant strains on biomaterials developed.</td>
</tr>
<tr>   <th class="THBlue">What are the specific objectives of the work with biohazardous materials?</th>
</tr>
<tr>   <td class="TDBlue"> The specific objective to work with biohazardous materials (i.e. cells, cadaveric tissues, proteins) is to investigate how they interact with the designed biomaterial scaffolds in vitro. This work will provide feedback on how to design better biomaterials to improve  tissue regeneration. Human cell lines will be utilized to closely examine how specific cells may react with the scaffolds.
We do not use recombinant methods or transgenic organisms. Our cells are established cell lines from ATCC and established stem cells at UCR Stem cell core.
The objective is to test bacterial and microbial response to novel antimicrobial biomaterials for biomedical applicaitons. Non pathogenic and pathogenic bacteria and yeast will be used.</td>
</tr>
</table>
<br><br><div class="hdg2">Potentially Biohazadous Materials</div>Please indicate yes or no if the following biohazardous materials are used currently within your laboratory or are proposed with the next year.  Please check all that apply.<table width="100%" border="0" cellpadding="0" cellspacing="0">
<tr>   <th colspan="2"><span class="hdg3">Human or Animal Infectious Agents</span></th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">True</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">True</td>
</tr>
<tr>   <th class="THLine2">Prions</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Plant Infectious Agents</span>
</th>
</tr>
<tr>   <th class="THLine1">Viruses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Bacteria</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Fungi</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Other</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Recombinant DNA</span>
</th>
</tr>
<tr>   <th class="THLine1">Recombinant DNA in any form.</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Intentional release to the environment</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Transgenic Plants</span>
</th>
</tr>
<tr>   <th class="THLine1">Plants</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Liverworts</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Mosses</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Algae</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Animals</span>
</th>
</tr>
<tr>   <th class="THLine1">Animals that are potential reservoirs of zoonotic diseases<br>(primates, wild animals, etc.)</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Infectious or hazardous agents in animals</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Human or primate cells in animals</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Transgenic animals</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Invertebrates</span>
</th>
</tr>
<tr>   <th class="THLine1">Exotic Arthropods</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Nematodes</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Intentional release to the environment</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th class="THLine2">Transgenic Insects</th>   <td class="TDLine2">False</td>
</tr>
<tr>   <th class="THLine1">Other</th>   <td class="TDLine1">False</td>
</tr>
<tr>   <th colspan="2">
<br><span class="hdg3">Human Stem Cells</span>
</th>
</tr>
<tr>   <th class="THLine1">Human Stem Cells</th>   <td class="TDLine1">True</td>
</tr>
</table>
<br><div class="hdg2">Human or Animal Infectious Agents</div>
<table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">List of Agents &#160;&#160;&#160;</th>   <th class="THBlue">Host of Range of Agent &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">human cell lines - no expected pathogens&#160;&#160;&#160;</td>   <td class="TDBlue">human, if any unexpected pathogen&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">sheep tissues (e.g. knee joint) - 70% Q-fever positive&#160;&#160;&#160;</td>   <td class="TDBlue">human, sheep, cow, large farm animals&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Q-fever bacteria&#160;&#160;&#160;</td>   <td class="TDBlue">sheep, human&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">E. coli&#160;&#160;&#160;</td>   <td class="TDBlue">human&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">human adult stem cells - no expected pathogens&#160;&#160;&#160;</td>   <td class="TDBlue">human, if any unexpected pathogen&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">cells isolated from animals - no expected pathogens&#160;&#160;&#160;</td>   <td class="TDBlue">rat, mice, rabbit, sheep, pig, dog, large farm animals&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">bacteria (Enterobacter aerogenes ATCC 35028,Bacillus subtilis ATCC 7060,
Serratia marcescens ATCC 8195, S. Epidermidis), Pseduomonas aeruginosa (ATCC 29260), Staphylococcus aureus(ATCC 25923), Methic&#160;&#160;&#160;</td>   <td class="TDBlue">human&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Yeasts (Candida albican, Candida glabrata, and their drug-resistant strains)&#160;&#160;&#160;</td>   <td class="TDBlue">Human&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">MRSA&#160;&#160;&#160;</td>   <td class="TDBlue">Human&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th width="50%" class="THBlue">Are you using the wild-type of the agent?</th>   <td width="50%" class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">Are you using genetically modified infectious agents (rDNA, mutagenesis, etc.)?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe the agent and any potential safety issues.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Do the experiments have the potential to increase the host range of the agent?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Is the vector replication competent?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">Are you using fusion proteins or cell entry domains?</th>   <td class="TDBlue">False</td>
</tr>
<tr>   <th class="THBlue">If &#8220;yes,&#8221; please describe any safety precautions you would recommend.</th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Are you using human or primate blood, blood products, cells, cell lines or tissues</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">If &#147;yes,&#148; please describe the blood, blood products, cells, cell lines or tissue and detail how the sample will be worked with during experimentation. Please include vendor information such as the ATCC number if available.</th>   <td class="TDBlue">primary human cartilage tissue; human osteoblast cell line; human osteoclast, human chondrocytes; human fibroblasts; human endothelial cells; human smooth muscle cells; human mesenchymal stem cells; embryonic stem cells - H9 (some GFP positive); Riv9 induced pluripotent human cells (some GFP positive); human neural stem cells, human neural cells, fresh human blood, human adipose derived stem cells, bone marrow derived mesenchymal stem cells.</td>
</tr>
</table>
<br><div class="hdg2">Human Stem Cells</div>
<b>Complete the following for each line obtained from a source outside of UCR.</b><table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">Line &#160;&#160;&#160;</th>   <th class="THBlue">Cell Type &#160;&#160;&#160;</th>   <th class="THBlue">NIH Registry &#160;&#160;&#160;</th>   <th class="THBlue">Institution/Company &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">embryonic stem cells - H9 (some GFP positive); Riv9 induced pluripotent human cells (some GFP positive)&#160;&#160;&#160;</td>   <td class="TDBlue">H9 embryonic, Riv9  adult fibroblast   &#160;&#160;&#160;</td>   <td class="TDBlue">yes&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Human neural stem cells&#160;&#160;&#160;</td>   <td class="TDBlue">adult stem cells&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Human neural stem cells&#160;&#160;&#160;</td>   <td class="TDBlue">adult&#160;&#160;&#160;</td>   <td class="TDBlue">&#160;&#160;&#160;</td>   <td class="TDBlue">Laboratory of Dr. Evan Y. Snyder
Sanford Burnham Prebys Medical Discovery Institute, Center for Stem Cells &amp; Regenerative Medicine
Sanford Consortium for Regenerative Medicine
2880 Torrey Pines Scenic Drive, Room 2110-D, La Jolla, CA 92037
858-551-7641&#160;&#160;&#160;</td>
</tr>
</table>
<br><b>Complete the following for each line developed at UCR.</b><table width="100%" border="1" cellpadding="1" cellspacing="0">
<tr>   <th class="THBlue">Line &#160;&#160;&#160;</th>   <th class="THBlue">Cell Type &#160;&#160;&#160;</th>   <th class="THBlue">Institution/Clinician &#160;&#160;&#160;</th>
</tr>
<tr>   <td class="TDBlue">embryonic stem cells - H9 (some GFP positive); Riv9 induced pluripotent human cells (some GFP positive) &#160;&#160;&#160;</td>   <td class="TDBlue">H9 embryonic, Riv9 adult fibroblast  &#160;&#160;&#160;</td>   <td class="TDBlue">Stem cell core &#160;&#160;&#160;</td>
</tr>
<tr>   <td class="TDBlue">Human Adipose derived stem cells&#160;&#160;&#160;</td>   <td class="TDBlue">adult stem cell&#160;&#160;&#160;</td>   <td class="TDBlue">UCR School of Medicine, Dr. Raj Vyass&#160;&#160;&#160;</td>
</tr>
</table>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue" colspan="2">For all stem cell lines, describe procedures that will be carried out to ensure safety (i.e. special handling conditions, tests for microbiological sterility, etc.).</th>
</tr>
<tr>   <td class="TDBlue" colspan="2">All stem cells will be handled following Biosafety level-2 guideline using a certified biosafety cabinet.</td>
</tr>
</table>
<br><br><div class="hdg2">Define Controls</div>
<table border="0" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue" width="50%">Do you need special equipment, engineering safeguards or personal protective equipment to maintain containment of your experiments (hoods, negative pressure rooms, gloves, etc.) </th>   <td class="TDBlue" width="50%">True</td>
</tr>
<tr>   <th class="THBlue"> If &#8220;yes&#8221;, list your recommendations.</th>   <td class="TDBlue">human cell lines will be handled in biosafety cabinet, personnel will wear appropriate PPE (lab coat, gloves).</td>
</tr>
<tr>   <th class="THBlue">Medical surveillance requirements or practices that you would recommend (antibody titering, etc.)? </th>   <td class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Suggested level of biological containment.</th>   <td class="TDBlue">BSL2</td>
</tr>
</table>
<br><div class="hdg2">Acknowledgement of Responsibilities</div>
<div class="tdBlue">For each of the elements below, please indicate if you will be following the UCR standard operating procedures and/or policies. If you indicate &#8220;yes&#8221; then you agree to and must follow the standard procedures and/or policies. If you answer &#8220;no,&#8221; please enter a brief description (in the space provided below the question) of the procedure you will follow and include a justification for deviating from the standard procedure and/or policy.</div>
<table border="0" width="100%" cellpadding="7" cellspacing="0">
<tr>   <th class="THBlue">Decontamination of biohazardous spills: I will used a 0.5 % sodium hypochlorite  (1:10 dilution of household bleach) to decontaminate equipment and work surfaces.  In locations where bleach would cause corrosion, I will decontaminate with an iodophor (e.g., Wescodyne).</th>   <td class="TDBlue" nowrap>True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">Storage: Biohazardous material will be clearly labeled with the universal biohazard symbol.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If I am using human or non-human primate blood or blood products, unfixed tissue, bodily fluids or organ or cell cultures of human origin, I will follow the exposure control plan for bloodborne pathogens.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">All injuries and accidental inoculation, ingestion or inhalation of biohazardous material will be reported immediately to the lab director or supervisor and EH&amp;S (827-2648).  Dial 911 immediately for any medical emergency.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">All shipments of biological materials will follow university policy and all applicable federal and international regulations whenever shipped domestically or internationally.  Proper importation or exportation permits and licenses will be obtained before shipping or reviving biological materials to or from any international location.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">If I am generating medical and/or biohazardous waste, I will abide by the UC Riverside Medical and/or Biological waste plans.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <td colspan="2" class="TDBlue"></td>
</tr>
<tr>   <th class="THBlue">I understand that UC Riverside may be required by law to release a copy of this application to the public.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I understand that failure to comply with the applicable regulations governing the use of biohazardous materials described above may result in suspension of the authorization and might jeopardize any funding supporting the activities described herein.</th>   <td class="TDBlue">True</td>
</tr>
<tr>   <th class="THBlue">I attest that I will conduct the study identified above in the manner described.  If I decide to make any changes in the procedure or if any problems occur which involve risk or the possibility of risk to others, I will immediately report such occurances or contemplated changes to the UCR Institutional Biosafety Committee, Research and Economic Development, 200 University Office Building, ext 2-4809; IBC@ucr.edu.</th>   <td class="TDBlue">True</td>
</tr>
</table>
<br><table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>______________________________</td>
<td>___________</td>
<td rowspan="2">&#160;&#160;&#160;&#160;</td>
<td>______________________________</td>
<td>___________</td>
</tr>
<tr>
<td>Principal Investigator</td>
<td>Date</td>
<td>Co-Investigator</td>
<td>Date</td>
</tr>
</table>
<br><em>Electronically signed and submitted to ORA on 6/20/2017 8:04:22 AM by <b>Huinan Liu</b></em><hr>IBC CERTIFICATION<div class="tdBlue">I certify that the Institutional Biosafety Committee has reviewed the proposed project.  In compliance with NIH guidelines and other specific NIH instructions, the project is (check one)<br><img src="/appAsp/images/CheckBox.gif"> Approved as is.<br><img src="/appAsp/images/CheckBox.gif"> Approved with the following conditions:<br><img src="/appAsp/images/CheckedBox.gif"> Approved with the following special conditions:<ul><li>
<b>Bloodborne Pathogens Training</b> is required for anyone working with bloodborne pathogens; human or primate derived blood products such as whole blood, plasma, serum, platelets, or white cells; unfixed human or primate tissue; human or primate body fluids potentially containing blood such as semen, cerebrospinal fluid, vaginal secretions, amniotic fluid (but not including urine, feces, vomit, tears, sweat, sputum, nasal secretions, and saliva); human cell lines; or individuals entering areas where others work with the above materials and perform tasks where any of those materials may come into contact with their skin or mucous membranes. This training is available online at the following link: <a href="http://www.ehs.ucr.edu/training/online/bbp/indexlms.html" target="_blank">http://www.ehs.ucr.edu/training/online/bbp/indexlms.html</a>.  In addition to training, an exposure control plan for bloodborne pathogens must be completed and kept in the lab. The following link contains a generic plan that can be customized for your facility or department: <a href="http://ehs.ucr.edu/biosafety/exposurecontrolplantemplate.pdf" target="_blank">http://ehs.ucr.edu/biosafety/exposurecontrolplantemplate.pdf</a>.  Finally, a copy of the Bloodborne Pathogen standard must be printed out and available in the laboratory. The Standard is located online at this address: <a href="https://www.dir.ca.gov/title8/5193.html" target="_blank">https://www.dir.ca.gov/title8/5193.html</a>.  For more information, contact the Biosafety Officer, at x25528.<br><br><br>
</li></ul>
</div>
<table border="0" width="100%" cellpadding="0" cellspacing="0">
<tr>
<td>Level:	<img src="/appAsp/images/CheckBox.gif">BL1 &#160;&#160;<img src="/appAsp/images/CheckedBox.gif">BL2 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL3 &#160;&#160;<img src="/appAsp/images/CheckBox.gif">BL4 &#160;&#160;</td>
<td>
<em>Electronically Signed by<br><u><b>Djurdjica Coss</b></u></em> __________________________7/7/2017</td>
</tr>
<tr>
<td>&#160;</td>
<td>Chair-Institutional Biosafety Committee &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; Date</td>
</tr>
</table>
                    <!-- End Outer Table -->
                </td>
            </tr>
        </table>
    
</td>
</tr>
</table>
</form>
</body>
</html>
